Cargando…

Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis

BACKGROUND AND OBJECTIVE: Renal artery stenosis (RAS) is associated with an increased risk of renal function deterioration (RFD). Our previous study showed that renal cortical blood perfusion assessed by contrast-enhanced ultrasound (CEUS) was an important related factor for RFD in RAS patients. Bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Ma, Na, Zhang, Yuewei, Wang, Siyu, Sun, Youjing, Li, Mengpu, Ai, Hu, Zhu, Hui, Wang, Yang, Li, Peng, Guo, Fajin, Li, Yongjun, Ren, Junhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035536/
https://www.ncbi.nlm.nih.gov/pubmed/35479955
http://dx.doi.org/10.3389/fmed.2022.783994
_version_ 1784693314053734400
author Li, Yan
Ma, Na
Zhang, Yuewei
Wang, Siyu
Sun, Youjing
Li, Mengpu
Ai, Hu
Zhu, Hui
Wang, Yang
Li, Peng
Guo, Fajin
Li, Yongjun
Ren, Junhong
author_facet Li, Yan
Ma, Na
Zhang, Yuewei
Wang, Siyu
Sun, Youjing
Li, Mengpu
Ai, Hu
Zhu, Hui
Wang, Yang
Li, Peng
Guo, Fajin
Li, Yongjun
Ren, Junhong
author_sort Li, Yan
collection PubMed
description BACKGROUND AND OBJECTIVE: Renal artery stenosis (RAS) is associated with an increased risk of renal function deterioration (RFD). Our previous study showed that renal cortical blood perfusion assessed by contrast-enhanced ultrasound (CEUS) was an important related factor for RFD in RAS patients. Based on several conventional related factors confirmed by previous studies, we aimed to establish and verify a CEUS+ scoring system to evaluate the risk of RFD at 1 year of follow-up in RAS patients. METHODS: This study was a single-center retrospective study. A total of 497 elderly RAS patients (247 in the training group and 250 in the verification group) admitted to the Beijing Hospital from January 2016 to December 2019 were included. The baseline characteristics of the patients on admission (including general conditions, previous medical history, blood pressure, blood creatinine, RAS, and cortical blood perfusion in the affected kidney) and renal function [glomerular filtration rate (GFR)] at 1-year of follow-up were collected. We used the univariate and multivariate logistic regressions to establish a CEUS+ scoring system model, the receiver operating characteristic (ROC) curve and area under the curve (AUC) to evaluate prediction accuracy, and the decision curve analysis and nomogram to evaluate the clinical application value of CEUS+ scoring system model. RESULTS: Among the 497 patients enrolled, 266 (53.5%) were men, with an average age of (51.7 ± 19.3) years. The baseline clinical-radiomic data of the training group and the verification group were similar (all p > 0.05). Multivariate logistic regression analysis results showed that age [Odds ratio (OR) = 1.937, 95% confidence interval (CI): 1.104–3.397), diabetes (OR = 1.402, 95% CI: 1.015–1.938), blood pressure (OR = 1.575, 95% CI: 1.138–2.182), RAS (OR = 1.771, 95% CI: 1.114–2.816), and area under ascending curve (AUCi) (OR = 2.131, 95% CI: 1.263–3.596) were related factors for the renal function deterioration after 1 year of follow-up (all p < 0.05). The AUC of the ROC curve of the CEUS+ scoring system model of the training group was 0.801, and the Youden index was 0.725 (specificity 0.768, sensitivity 0.813); the AUC of the ROC curve of the validation group was 0.853, Youden index was 0.718 (specificity 0.693, sensitivity 0.835). There was no significant difference in ROC curves between the two groups (D = 1.338, p = 0.325). In addition, the calibration charts of the training and verification groups showed that the calibration curve of the CEUS+ scoring system was close to the standard curve (p = 0.701, p = 0.823, both p > 0.10). CONCLUSION: The CEUS+ scoring system model is helpful in predicting the risk of worsening renal function in elderly RAS patients.
format Online
Article
Text
id pubmed-9035536
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90355362022-04-26 Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis Li, Yan Ma, Na Zhang, Yuewei Wang, Siyu Sun, Youjing Li, Mengpu Ai, Hu Zhu, Hui Wang, Yang Li, Peng Guo, Fajin Li, Yongjun Ren, Junhong Front Med (Lausanne) Medicine BACKGROUND AND OBJECTIVE: Renal artery stenosis (RAS) is associated with an increased risk of renal function deterioration (RFD). Our previous study showed that renal cortical blood perfusion assessed by contrast-enhanced ultrasound (CEUS) was an important related factor for RFD in RAS patients. Based on several conventional related factors confirmed by previous studies, we aimed to establish and verify a CEUS+ scoring system to evaluate the risk of RFD at 1 year of follow-up in RAS patients. METHODS: This study was a single-center retrospective study. A total of 497 elderly RAS patients (247 in the training group and 250 in the verification group) admitted to the Beijing Hospital from January 2016 to December 2019 were included. The baseline characteristics of the patients on admission (including general conditions, previous medical history, blood pressure, blood creatinine, RAS, and cortical blood perfusion in the affected kidney) and renal function [glomerular filtration rate (GFR)] at 1-year of follow-up were collected. We used the univariate and multivariate logistic regressions to establish a CEUS+ scoring system model, the receiver operating characteristic (ROC) curve and area under the curve (AUC) to evaluate prediction accuracy, and the decision curve analysis and nomogram to evaluate the clinical application value of CEUS+ scoring system model. RESULTS: Among the 497 patients enrolled, 266 (53.5%) were men, with an average age of (51.7 ± 19.3) years. The baseline clinical-radiomic data of the training group and the verification group were similar (all p > 0.05). Multivariate logistic regression analysis results showed that age [Odds ratio (OR) = 1.937, 95% confidence interval (CI): 1.104–3.397), diabetes (OR = 1.402, 95% CI: 1.015–1.938), blood pressure (OR = 1.575, 95% CI: 1.138–2.182), RAS (OR = 1.771, 95% CI: 1.114–2.816), and area under ascending curve (AUCi) (OR = 2.131, 95% CI: 1.263–3.596) were related factors for the renal function deterioration after 1 year of follow-up (all p < 0.05). The AUC of the ROC curve of the CEUS+ scoring system model of the training group was 0.801, and the Youden index was 0.725 (specificity 0.768, sensitivity 0.813); the AUC of the ROC curve of the validation group was 0.853, Youden index was 0.718 (specificity 0.693, sensitivity 0.835). There was no significant difference in ROC curves between the two groups (D = 1.338, p = 0.325). In addition, the calibration charts of the training and verification groups showed that the calibration curve of the CEUS+ scoring system was close to the standard curve (p = 0.701, p = 0.823, both p > 0.10). CONCLUSION: The CEUS+ scoring system model is helpful in predicting the risk of worsening renal function in elderly RAS patients. Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9035536/ /pubmed/35479955 http://dx.doi.org/10.3389/fmed.2022.783994 Text en Copyright © 2022 Li, Ma, Zhang, Wang, Sun, Li, Ai, Zhu, Wang, Li, Guo, Li and Ren. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Li, Yan
Ma, Na
Zhang, Yuewei
Wang, Siyu
Sun, Youjing
Li, Mengpu
Ai, Hu
Zhu, Hui
Wang, Yang
Li, Peng
Guo, Fajin
Li, Yongjun
Ren, Junhong
Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
title Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
title_full Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
title_fullStr Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
title_full_unstemmed Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
title_short Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
title_sort development and validation of a prognostic nomogram for prognosis in patients with renal artery stenosis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035536/
https://www.ncbi.nlm.nih.gov/pubmed/35479955
http://dx.doi.org/10.3389/fmed.2022.783994
work_keys_str_mv AT liyan developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT mana developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT zhangyuewei developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT wangsiyu developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT sunyoujing developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT limengpu developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT aihu developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT zhuhui developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT wangyang developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT lipeng developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT guofajin developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT liyongjun developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis
AT renjunhong developmentandvalidationofaprognosticnomogramforprognosisinpatientswithrenalarterystenosis